Bad News

Idenix Midstage Studies Fall Short - Forbes.com

Drug developer Idenix Pharmaceuticals Inc. said Thursday two studies of a treatment for Hepatitis C failed to meet their primary goals. …

Get the word out! Sphere: Related Content

Discussion Area - Leave a Comment